Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
1.010
-0.010 (-0.98%)
At close: Nov 3, 2026, 4:00 PM EST
1.000
-0.010 (-0.99%)
Pre-market: Nov 4, 2026, 4:34 AM EST
Exicure Market Cap
Exicure has a market cap or net worth of $6.61 million as of November 3, 2026. It is the 43,553rd most valuable company in the world and the 5,812th biggest in the United States. Its market cap has decreased by 76.22% in one year.
Market Cap
6.61M
Enterprise Value
4.89M
1-Year Change
-76.22%
Global Rank
Country Rank
#5,812 United States
Category
ChartMarket Cap Chart
Since May 22, 2018, Exicure's market cap has decreased from $122.30M to $6.61M, a decrease of -94.59%. That is a compound annual growth rate of -29.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 6.61M | -80.84% |
| Dec 31, 2025 | 34.50M | 16.16% |
| Dec 31, 2024 | 29.70M | 494.00% |
| Dec 29, 2023 | 5.00M | -12.28% |
| Dec 30, 2022 | 5.70M | -67.98% |
| Dec 31, 2021 | 17.80M | -88.47% |
| Dec 31, 2020 | 154.40M | -28.95% |
| Dec 31, 2019 | 217.30M | 42.03% |
| Dec 31, 2018 | 153.00M | 25.10% |
| May 22, 2018 | 122.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 7.25M |
| CNS Pharmaceuticals | 6.81M |
| Enveric Biosciences | 6.67M |
| FibroBiologics | 6.47M |
| XTL Biopharmaceuticals | 6.27M |
| Aprea Therapeutics | 6.23M |
| Processa Pharmaceuticals | 6.20M |
| Skye Bioscience | 5.98M |